11:10 AM EDT, 07/01/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were higher Monday, rising 0.55% to 1,427.31 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Genfit ( GNFT ) and semiconductor company Sequans Communications ( SQNS ) , which climbed 11% and 5.5%, respectively. They were followed by biopharmaceutical company DBV Technologies ( DBVT ) and travel company trivago (TRVG), which increased 3.6% and 3.5%, respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS ( EDAP ) and software firm SAP (SAP), which dropped 4.1% and 1.3%, respectively. They were followed by telecommunications company VEON (VEON) and pharmaceutical company Ascendis Pharma ( ASND ) , which were down 0.9% and 0.7%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and Adaptimmune Therapeutics ( ADAP ) , which climbed 11% and 5.6%, respectively. They were followed by biopharmaceutical company NuCana ( NCNA ) and financial services company Lloyds Banking Group ( LYG ) , which were up 4.7% and 2%, respectively.

The decliners from the UK and Ireland were led by cruise line operator Carnival (CUK) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which were down 5.1% and 4%, respectively. They were followed by construction materials supplier CRH (CRH) and hospitality company InterContinental Hotels Group ( IHG ) , which fell 2.6% and 2.5%, respectively.